⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OCS News
Oculis Holding AG Ordinary shares
Oculis Announces Resignation of Lionel Carnot from Board of Directors
globenewswire.com
OCS
Oculis Announces Resignation of Lionel Carnot from Board of Directors
globenewswire.com
OCS
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
globenewswire.com
OCS
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
globenewswire.com
OCS
OCSL
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
globenewswire.com
OCS
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
globenewswire.com
OCS
Oculis Reports Q2 2026 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q2 2026 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q2 2026 Financial Results and Provides Company Update
globenewswire.com
OCS
Oculis Reports Q2 2026 Financial Results and Provides Company Update
globenewswire.com
OCS